MN HF2962

Authorizes Minnesota pharmacists to prescribe FDA-approved tobacco cessation medications (excluding bupropion), opiate antagonists for treating opioid overdose, and travel medications recommended by the Centers for Disease Control and Prevention

Requires pharmacists prescribing these medications to provide patients with a written record and prohibits delegation of prescribing authority to others (though registered pharmacy interns may prepare prescriptions for pharmacist review and approval)

Directs the state pharmacy board to develop standardized protocols for pharmacist prescribing in consultation with the Minnesota Board of Medical Practice, Board of Nursing, commissioner of health, and relevant professional associations

Defines "practitioner" to include pharmacists authorized to prescribe these medications for specific statutory sections relating to drug therapy management

Ensures that all state and federal insurance coverage laws applicable to these medications apply when prescribed by pharmacists